We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+7.07%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$7.57B
AUM Growth
+$643M
(+9.3%)
Cap. Flow
+$235M
Cap. Flow
% of AUM
3.1%
Top 10 Holdings %
Top 10 Hldgs %
16.13%
Holding
1,154
New
305
Increased
228
Reduced
235
Closed
370
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$71M |
| 2 |
Baxter International
BAX
|
+$60.7M |
| 3 |
T-Mobile US
TMUS
|
+$60.1M |
| 4 |
Perrigo
PRGO
|
+$53.7M |
| 5 |
NRG Energy
NRG
|
+$50.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$68.2M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$53.3M |
| 3 |
Avient
AVNT
|
+$45.7M |
| 4 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$45.6M |
| 5 |
BHI
Baker Hughes
BHI
|
+$40.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.11% |
| 2 | Industrials | 11.84% |
| 3 | Consumer Discretionary | 11.65% |
| 4 | Technology | 10.61% |
| 5 | Financials | 10.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DOOR
451
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $2.07M | 0.03% |
+33,637
| New | +$1.9M |
|
452
FTI Consulting
FCN
$4.17B
| $2.06M | 0.03% |
53,437
-37,650
| -41% | -$1.43M |
|
453
CenterPoint Energy
CNP
$26.8B
| $2.05M | 0.03% |
+87,563
| New | +$2.09M |
|
454
BOK Financial
BOKF
$8.78B
| $2.04M | 0.03% |
+33,977
| New | +$2.19M |
|
455
Enova International
ENVA
$6.37B
| $2.02M | 0.03% |
+90,688
| New | +$2.06M |
|
456
United Parks & Resorts
PRKS
$2.09B
| $2.02M | 0.03% |
+112,620
| New | +$1.98M |
|
|
B
457
Barrick Mining
B
$69.3B
| $2.01M | 0.03% |
+186,760
| New | +$2.3M |
|
|
HMHC
458
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $2M | 0.03% |
+96,485
| New | +$1.93M |
|
|
GG
459
DELISTED
Goldcorp Inc
GG
| $1.98M | 0.03% |
+107,100
| New | +$2.2M |
|
460
Expeditors International
EXPD
$23.2B
| $1.98M | 0.03% |
+44,311
| New | +$1.9M |
|
|
MXIM
461
DELISTED
Maxim Integrated Products
MXIM
| $1.97M | 0.03% |
+61,900
| New | +$1.82M |
|
462
Anika Therapeutics
ANIK
$270M
| $1.97M | 0.03% |
48,281
-24,852
| -34% | -$971K |
|
|
ATML
463
DELISTED
ATMEL CORP
ATML
| $1.96M | 0.03% |
233,956
+99,443
| +74% | +$761K |
|
|
SDRL
464
DELISTED
Seadrill Limited Common Stock
SDRL
| $1.96M | 0.03% |
+614
| New | +$3.08M |
|
|
SHPG
465
DELISTED
Shire pic
SHPG
| $1.95M | 0.03% |
9,195
+7,178
| +356% | +$1.52M |
|
|
WBC
466
DELISTED
WABCO HOLDINGS INC.
WBC
| $1.93M | 0.03% |
+18,399
| New | +$1.82M |
|
|
CGI
467
DELISTED
Celadon Group Inc
CGI
| $1.93M | 0.03% |
+84,925
| New | +$1.77M |
|
468
Tapestry
TPR
$32.7B
| $1.92M | 0.03% |
51,019
-76,371
| -60% | -$2.69M |
|
469
Public Service Enterprise Group
PEG
$37.4B
| $1.91M | 0.03% |
+46,083
| New | +$1.85M |
|
|
TSL
470
DELISTED
Trina Solar Limited
TSL
| $1.9M | 0.03% |
204,961
-39,281
| -16% | -$386K |
|
|
IBKC
471
DELISTED
IBERIABANK Corp
IBKC
| $1.86M | 0.02% |
28,721
+9,884
| +52% | +$644K |
|
472
Bristol-Myers Squibb
BMY
$131B
| $1.83M | 0.02% |
30,961
-543,104
| -95% | -$30.6M |
|
|
BLCM
473
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $1.83M | 0.02% |
+7,935
| New | +$1.7M |
|
|
LLTC
474
DELISTED
Linear Technology Corp
LLTC
| $1.83M | 0.02% |
40,039
-563,669
| -93% | -$24.5M |
|
475
Newmont
NEM
$111B
| $1.81M | 0.02% |
+95,600
| New | +$1.93M |
|
Similar funds
Marshall Wace's Q4 2014 Portfolio in Review
As of Q4 2014, Marshall Wace held 1,154 positions worth $7.57B, up 9.3% from $6.93B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Marshall Wace deployed $235M of net new capital in Q4 2014, opening 305 new positions and adding to 228 existing holdings. Its largest new stake was Baxter International: 1,557,838 shares worth $62M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was Alibaba, an estimated $68.2M trimmed.
- Marshall Wace's largest Q4 2014 buy was Baxter International: 1,557,838 shares worth $62M.
- Marshall Wace added most to Allergan Inc in Q4 2014, an estimated $71M increase.
- Marshall Wace's biggest Q4 2014 reduction was Alibaba, cutting an estimated $68.2M.
- Marshall Wace fully exited Baker Hughes in Q4 2014, selling an estimated $40.5M.
- Marshall Wace's ten largest holdings make up 16% of its $7.57B portfolio in Q4 2014.
- Marshall Wace opened 305 new positions and closed 370 in Q4 2014.
- Marshall Wace's portfolio value rose 9.3% quarter-over-quarter to $7.57B.
Based on Marshall Wace's 13F filing for Q4 2014, filed 17 Feb 2015.